about the author

Josh Sullivan

josh@endpointsnews.com

author articles

Bank­rupt­cy judge: J&J can spin talc pow­der in­to dif­fer­ent com­pa­ny, po­ten­tial­ly slow­ing plain­tiff­s' pay­outs

4 years ago
Pharma

Covid-19 man­u­fac­tur­ing roundup: Pro­duc­tion ramp-ups ap­proved by EU; mR­NA boom spurs Lon­za­'s Chi­nese ex­pan­sion

4 years ago
Coronavirus
Manufacturing

Bio­Duro-Sun­dia plants its flag at for­mer Par man­u­fac­tur­ing site in CA

4 years ago
Outsourcing
Manufacturing

WuXi Bi­o­log­ics earns lo­cal nod for ex­pan­sion to grow­ing MA man­u­fac­tur­ing site

4 years ago
Manufacturing

Cipla re­opens South African man­u­fac­tur­ing site af­ter vi­o­lent protests

4 years ago
Manufacturing

FDA faults Japan­ese man­u­fac­tur­er with da­ta breach, con­t­a­m­i­nat­ed in­jecta­bles

4 years ago
FDA+
Manufacturing

Pfiz­er inks Latin Amer­i­can dis­tri­b­u­tion deal for now ful­ly ap­proved Covid-19 vac­cine

4 years ago
Coronavirus
Manufacturing

Covid-19 roundup: J&J of­fers new da­ta to sup­port boost­ers — but some ex­perts are not im­pressed; Thai­land ...

4 years ago
Coronavirus

As leader is freed from prison, Sam­sung Bi­o­log­ics nabs mas­sive in­vest­ment from par­ent com­pa­ny's $205B spend­ing spree

4 years ago
Outsourcing
Manufacturing

KalVista clears in­ter­na­tion­al reg­u­la­to­ry hur­dles on HAE tri­al; Elix­iron rais­es $27M in Se­ries A

4 years ago
News Briefing

Covid-19 roundup: The FDA has re­it­er­at­ed its warn­ing against par­a­site pre­ven­tion drug in­tend­ed for an­i­mals; Mod­er­na ...

4 years ago
Coronavirus

Covid-19 man­u­fac­tur­ing roundup: Sene­gal looks to get in the man­u­fac­tur­ing mix; As­pen vac­cine ex­ports part of ...

4 years ago
R&D
Manufacturing

As Cu­ria ex­pands, it will add API site in up­state New York; In bat­tle against food al­ler­gies, Al­ladapt to build site ...

4 years ago
R&D
Manufacturing

Mov­ing be­yond just sol­id dose, Re­cro Phar­ma is head­ed to San Diego with ac­qui­si­tion

4 years ago
R&D

FDA blasts In­di­an man­u­fac­tur­er's MD site for un­clean con­di­tions in Form 483 let­ter

4 years ago
Manufacturing

As de­mand for vac­cines grow, an Al­aba­ma vial mak­er lands an­oth­er fed­er­al con­tract

4 years ago
Coronavirus
Manufacturing

Re­call re­port: More Chan­tix lots pulled from shelves as ni­trosamine woes con­tin­ue

4 years ago
Manufacturing

Sesen Bio tri­al marred by mis­con­duct — re­port; Bris­tol My­ers picks up de­vel­op­ment of AI out­fit's im­munol­o­gy drug

4 years ago
News Briefing

Through a man­u­fac­tur­ing deal, Africa was sup­posed to fi­nal­ly get up to speed on Covid-19 vac­cines. Now, those have ...

4 years ago
Coronavirus
Manufacturing

Af­ter the long, gru­el­ing path to EUA, Roche says there is a sup­ply short­age of Actem­ra

4 years ago
Pharma
Coronavirus

Can­cer spe­cial­ist Hi­ber­Cell snaps up an­a­lyt­ics, com­pu­ta­tion­al tools in all-stock buy­out; Prax­is re­veals new ...

4 years ago
News Briefing

Covid-19 roundup: Tiny sam­ple size leads FDA to turn down Rigel's EUA; Seat­tle biotech to co-de­vel­op mR­NA vac­cine in ...

4 years ago
R&D
Coronavirus

Covid-19 roundup: Io­n­is joins ranks of firms man­dat­ing Covid-19 vac­cine for staffers; Boost­ers are big mon­ey — ...

4 years ago
Coronavirus

No­vavax, Fu­ji­film plow ahead on Covid-19 vac­cine pro­duc­tion de­spite OWS set­back

4 years ago
Coronavirus
Manufacturing
First page Previous page 14151617181920 Next page Last page
A service from the Financial Times